Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab for eczema may cause hair loss.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Both immature and mature fat cells are important for hair growth cycles, with immature cells promoting growth and mature cells possibly inhibiting it.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Researchers developed a mouse model that tracks hair growth using bioluminescence, improving accuracy in studying hair cycles.

Effective treatments for severe alopecia areata are still lacking.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.